Sarah Greene

649 total citations
5 papers, 516 citations indexed

About

Sarah Greene is a scholar working on Oncology, Immunology and Infectious Diseases. According to data from OpenAlex, Sarah Greene has authored 5 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 0 papers in Infectious Diseases. Recurrent topics in Sarah Greene's work include Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (3 papers) and CAR-T cell therapy research (3 papers). Sarah Greene is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (3 papers) and CAR-T cell therapy research (3 papers). Sarah Greene collaborates with scholars based in United States and Germany. Sarah Greene's co-authors include Clint Allen, Yvette Robbins, Jay Friedman, Paúl E. Clavijo, Jeffrey Schlom, Claudia Palena, Dean Y. Maeda, John A. Zebala, Lucas A. Horn and Nicole C. Schmitt and has published in prestigious journals such as Clinical Cancer Research, eLife and Oral Oncology.

In The Last Decade

Sarah Greene

5 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Greene United States	5	393	370	81	40	36	5	516
Lillian Sun United States	7	298 0.8×	378 1.0×	120 1.5×	63 1.6×	36 1.0×	9	508
Sheryl Kunning United States	7	305 0.8×	344 0.9×	108 1.3×	71 1.8×	57 1.6×	10	503
Kelli A. Connolly United States	6	312 0.8×	305 0.8×	113 1.4×	56 1.4×	52 1.4×	13	479
Ayana T. Ruffin United States	5	234 0.6×	292 0.8×	133 1.6×	82 2.0×	75 2.1×	12	479
Carla Costa-Nunes Switzerland	3	368 0.9×	381 1.0×	87 1.1×	44 1.1×	33 0.9×	3	483
Philipp Knopf Germany	5	201 0.5×	286 0.8×	55 0.7×	41 1.0×	30 0.8×	10	357
Haejung Won United States	10	311 0.8×	293 0.8×	213 2.6×	90 2.3×	78 2.2×	12	563
Mónica Bernal Spain	9	297 0.8×	278 0.8×	84 1.0×	40 1.0×	46 1.3×	15	448
Yinjun He China	6	154 0.4×	204 0.6×	93 1.1×	41 1.0×	35 1.0×	9	300
Rebecca Wijers Netherlands	8	174 0.4×	245 0.7×	89 1.1×	52 1.3×	43 1.2×	13	337

Countries citing papers authored by Sarah Greene

Since Specialization

Citations

This map shows the geographic impact of Sarah Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Greene more than expected).

Fields of papers citing papers by Sarah Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Greene. The network helps show where Sarah Greene may publish in the future.

Co-authorship network of co-authors of Sarah Greene

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Greene. A scholar is included among the top collaborators of Sarah Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Greene. Sarah Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Robbins, Yvette, Sarah Greene, Jay Friedman, et al.. (2020). Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells. eLife. 9. 43 indexed citations

2.

Greene, Sarah, Yvette Robbins, Wojciech K. Mydlarz, et al.. (2019). Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models. Clinical Cancer Research. 26(6). 1420–1431. 217 indexed citations

3.

Friedman, Jay, Ellen Moore, Paul Zolkind, et al.. (2019). Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells. Clinical Cancer Research. 26(3). 679–689. 57 indexed citations

4.

Sun, Lillian, Paúl E. Clavijo, Yvette Robbins, et al.. (2019). Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. JCI Insight. 4(7). 188 indexed citations

5.

Greene, Sarah, Priya Patel, & Clint Allen. (2019). How patients with an intact immune system develop head and neck cancer. Oral Oncology. 92. 26–32. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact